Aclaris Therapeutics, Inc. (ACRS)

5.725 +0.16 (+2.78%) USD  |  NASDAQ  |  Sep 22, 16:00
5.725 0.00 (0.00%) After-Hours: 20:00
More

Aclaris Therapeutics Price to CFO Per Share (TTM)

Price to CFO Per Share (TTM) Chart

View Price to CFO Per Share (TTM) for ACRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to CFO Per Share (TTM) Chart
Start Trial

Historical Price to CFO Per Share (TTM) Data

View and export this data back to . Start Trial.
Date Value
September 22, 2026 --

Price to CFO Per Share (TTM) Range, Past 5 Years

View Price to CFO Per Share (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to CFO Per Share (TTM) Benchmarks

View Price to CFO Per Share (TTM) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Nektar Therapeutics --
Xeris Biopharma Holdings, Inc. Upgrade
Alumis, Inc. --
ANI Pharmaceuticals, Inc. Upgrade